Focus on lymphangiogenesis in tumor metastasis
- 1 February 2005
- journal article
- review article
- Published by Elsevier in Cancer Cell
- Vol. 7 (2), 121-127
- https://doi.org/10.1016/j.ccr.2005.01.017
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Vascular Endothelial Growth Factor D Is Dispensable for Development of the Lymphatic SystemMolecular and Cellular Biology, 2005
- Vascular endothelial growth factor‐C gene therapy restores lymphatic flow across incision woundsThe FASEB Journal, 2004
- Adenoviral Catheter-Mediated Intramyocardial Gene Transfer Using the Mature Form of Vascular Endothelial Growth Factor-D Induces Transmural Angiogenesis in Porcine HeartCirculation, 2004
- Role of lymphangiogenic factors in tumor metastasisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2004
- Therapeutic lymphangiogenesis with human recombinant VEGF‐CThe FASEB Journal, 2002
- Molecular control of lymphangiogenesisBioEssays, 2002
- Lymphangiogenic Gene Therapy With Minimal Blood Vascular Side EffectsThe Journal of Experimental Medicine, 2002
- The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissuesThe FASEB Journal, 2002
- Mouse LYVE-1 Is an Endocytic Receptor for Hyaluronan in Lymphatic EndotheliumJournal of Biological Chemistry, 2001
- VEGF‐C and VEGF‐D expression in neuroendocrine cells and their receptor, VEGFR‐3, in fenestrated blood vessels in human tissuesThe FASEB Journal, 2000